Infinity Medicald's portfolio company CytoReason, a leading developer of computational disease models for efficient drug discovery and development, today announced the extension of its collaboration agreement with Pfizer!
Nanomedic has developed an innovative and first-of-its-kind device - “Electrospinning Portable”, for the treatment and healing of complex burns and wounds by using a polymer matrix printed on the patient…
China’s Capital Market: The Main Growth Engine of 2020s Foreign Capital Opportunities in China and CICC Capital Markets Case Study: Electric Cars & Medical Trends Capital Markets Investment Opportunities &…
“The Corona virus uncovered the failures of the healthcare system, one of them is the ability to integrate new technologies within the traditional healthcare systems” Amir Gal-Or, CO-Founder of Infinity…
Chinese Synopharm belongs to the group of companies from which the Chinese vaccine to Corona came, “The company will set up an office for locating Israeli collaborations within the offices…
A series of additional steps that China is taking for the first time will open its financial markets to foreign investors
In an interview with Walla, Dr. Yuval Bloch, CEO of Infinity Medical, explains how medical experience connects to the world of investments. “I bring the end user point of view.…
With a meteoric rise in business activity and the IPO market alongside government support to bolster the Shanghai Stock Exchange, the Chinese capital market is gradually realizing its potential to…
Prof. Rivka Carmi, former President of Ben-Gurion University, has been appointed director of the Infinity Medical (IMED) R&D Partnership for Investment in Digital Medical Companies with an emphasis on advanced…
Infinity Medical (IMED) has signed a partnership with GuoJian Capital who manages 130 billion yuan in investments
